Physician profile
John Hall
NPI 1932599321
$712.20
in general payments reported to CMS, 2019-2025
12 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.18 · 2022: $109 · 2023: $185 · 2024: $226 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $224.13 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $216.00 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $68.19 | 2024-2025 | Airsupra |
| Ironshore Pharmaceuticals INC. | $47.85 | 2023-2024 | Jornay Pm |
| Abbott Laboratories | $31.83 | 2021-2023 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.93 | 2022-2023 | Xifaxan |
| Abbvie INC. | $18.31 | 2022 | |
| Axsome Therapeutics, INC. | $17.99 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.16 | 2021 | |
| Pfizer INC. | $14.49 | 2023 | |
| Lundbeck LLC | $14.29 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.